How a California biotech briefly tripled its value by hyping a Covid-19 ‘cure’
Last week, a California biotech called Sorrento Therapeutics emailed reporters about the discovery of an “exceptionally potent antibody” for Covid-19. Then the CEO, Henry Ji, got a Fox News reporter on the phone and told him that there was a cure, that the crisis would be over.
“We want to emphasize there is a cure. There is a solution that works 100 percent,” Ji said. “If we have the neutralizing antibody in your body, you don’t need the social distancing. You can open up a society without fear.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 90,300+ biopharma pros reading Endpoints daily — and it's free.